Washington (AP) — President Joe Biden’s COVID-19 vaccination campaign failed when federal regulators recommended a “pause” when managing Johnson & Johnson injections. However, the White House described the action as an important validation of his measured approach throughout the rollout.
Biden received a large supply of Pfizer and Moderna vaccines on Tuesday, even if J & J’s one-shot vaccine was temporarily lost, “basically 100% doubtful for all lonely Americans. No. “
But polls suggest that tens of millions of Americans are hesitant to take shots that public health professionals say the country needs, perhaps more than supply concerns. Also of concern is the potential blow to public confidence in all vaccines. Get out of the pandemic.
Biden and the Supreme Health officials said in a White House briefing that the suspension should actually have the opposite effect and raise confidence that the government puts safety first.The· Advice from the Food and Drug Administration and the Centers for Disease Control and Prevention Citing the need to investigate reports of rare but potentially dangerous blood clots, “prove how serious we are about safety,” said Anthony, an infectious disease expert in the United States. Dr. Fauci said.
At the beginning of his inauguration, Biden prioritized a strong response to the virus that killed 559,000 Americans and launched a vaccine campaign in which nearly 50% of adults received at least one vaccination.
His behavior is generally highly regarded, and hesitation towards vaccination gradually diminishes as vaccinations increase. Biden has been criticized for not sharing vaccines with other countries, as three vaccines are used in the United States and are well supplied in the pipeline. The president said Tuesday’s actions proved the wisdom of his approach.
“My message to the American people about vaccines, I told all of you,” Biden told reporters after the announcement, confirming that there were “600 million doses” from Pfizer and Moderna in the pipeline. I did. “
Johnson & Johnson’s suspension, which regulators say they want to resolve within a few days, occurs shortly after a production problem at the Baltimore plant that produces the J & J vaccine.
The White House, which was notified about 12 hours before some sort of announcement and had no prior warning about what the FDA and CDC were doing, acted swiftly to minimize concerns about its implications. .. The aide realized that the decision must be portrayed as ensuring a “gold standard” of safety to avoid falling into the vaccine hesitation.
“In fact, I think it’s a very strong debate about safety,” Forch said.
The White House Coronavirus Coordinator Jeff Seiens added that the suspension by the authorities “should reassure the American people that they are very diligent and conservative about how they approach vaccines.” ..
They promise that the suspension will share excess vaccine with the world due to the prudence of Biden’s cautious approach to promises on vaccine supply and delivery, and concerns about such potential setbacks. In particular, he claimed that his administration proved to be reluctant.
“They are clearly trying to reassure people that there is a supply, and it will be safe,” said Jennifer Palmieri, former White House Communications Director. “I don’t want this to happen, but in terms of what your tools are when it happens, they use the best: the president, the best people you can trust, and the best professionals. I did it. “
Due to supply issues, J & J Shots reflected a small portion of the dose, but was one of the most promising vaccines due to its ease of administration and distribution. By the end of May, the United States still expects all adult Americans to receive enough of the other two approved vaccines to receive injections, Zyentz said. This week, Moderna and Pfizer have given the federal government 28 million doses. That’s enough for the current number of shots per day to exceed 3 million.
Zyents acknowledged that Tuesday’s announcement could have surprised some states, but said it reflected the speed at which authorities moved to address safety concerns. .. He added that it is evidence of Biden’s commitment to “follow science” in responding to a pandemic.
“We want science institutions to lead science,” Zients said, saying that no one in the White House was involved in the decision to suspend. “There is no reason for us to be involved in scientific decisions. We bring nothing to the table.”
Officials said Tuesday that they were investigating an abnormal blood clot in six of the more than 7.2 million adults who were shot. One of the patients has died and the other remains hospitalized in a serious condition.
Authorities said the delay was related to educating doctors on the unique ways in which blood clots had to be treated, as well as their desire to study very rare side effects. They said that conventional treatment with the anticoagulant heparin could lead to outcomes in dangerous patients.
Fauci spoke at the White House and advised those who recently took J & J shots, “I remember that anxiety reactions are less than one millionth, so don’t cause anxiety reactions.” “But that said, pay attention to potential symptoms of blood clots such as severe headaches, abdominal or lower limb pain, and shortness of breath,” he added.
Dr. Mati Hlatshwayo Davis, an infectious disease specialist at the John Cochran VA Medical Center and the St. Louis Board of Health, said the suspension of J & J could affect the overall reliability of the vaccine, but transparency is , Minimum capture of shots.
“Today was such a sign of strength and leadership in rebuilding trust in these communities, and an improved direction,” she said of the Biden administration’s candidness on this issue. “They knew what was at stake and came to us as soon as this information became available.”
“They trust the American people, which gives these communities a reason to trust them,” she said.